What is it about?
This study uses molecular docking and molecular dynamics simulations to screen 14 natural terpenoids and limonoids against two SARS‑CoV‑2 targets: the spike protein RBD and the main protease (Mpro). While docking suggested affinity for both targets, longer simulations clarified which interactions remain stable over time.
Featured Image
Photo by Fusion Medical Animation on Unsplash
Why is it important?
The results highlight that some limonoids (deacetylnomilin, ichangin, nomilin) and the terpenoid β‑amyrin show stable interactions with SARS‑CoV‑2 Mpro, including contacts with the catalytic dyad. In contrast, interactions with the spike RBD were not maintained during dynamics, refining expectations about entry inhibition.
Perspectives
The work is fully in silico and focused on protein–ligand interactions and predicted ADME properties. Experimental validation in vitro and in vivo is required to confirm antiviral activity and clarify mechanisms. The multifactorial nature of terpenoids suggests additional, indirect effects beyond direct viral protein inhibition.
Prof. Antonio Speciale
University of Messina
Read the Original
This page is a summary of: Interaction of selected terpenoids with two SARS-CoV-2 key therapeutic targets: An in silico study through molecular docking and dynamics simulations, Computers in Biology and Medicine, July 2021, Elsevier,
DOI: 10.1016/j.compbiomed.2021.104538.
You can read the full text:
Contributors
The following have contributed to this page
